CardioNet

Jefferies is out with its report today on CardioNet (NASDAQ: BEAT), lowering its price target from $6 to $5. In a note to clients, Jefferies writes, "BEAT reported weak Q4:10 results with slightly lower revenues and larger-than-expected losses. We remain sidelined into another challenging year. We...

Jefferies & Company has lowered the price target on CardioNet (NASDAQ: BEAT) from $6 to $5 and maintains its Hold rating.

The day after reporting its financial results, CardioNet, Inc. (Nasdaq: BEAT) shares opened strong and continued their surge during the early trading hours, before steadily falling for most of the day. Still, by late afternoon the shares were holding onto gains of more than 8%. The CardioNet shares...